{"entity":{"type":"insider","cik":"0001398595","url":"/insider/0001398595","json_url":"/insider/0001398595.json","name":"Fitzpatrick Alexander A","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":8,"first":"2011-08-22","last":"2026-06-12","span_basis":"filed_date"},"name_variants":[{"name":"Fitzpatrick Alexander A","source":"filing","n_filings":8,"first_seen":"2011-08-22","last_seen":"2026-06-12"}],"transactions":[{"id":6091581,"accession":"0001398595-26-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001398595-26-000004","line_url":"/filing/0001398595-26-000004#line-1","is_derivative":false,"issuer_cik":"0001398595","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001398595","owner_cik":"0001398595","owner_name":"Fitzpatrick Alexander A","owner_display_name":"Fitzpatrick Alexander A","owner_url":"/insider/0001398595","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3355.0,"shares_display":"3,355","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":33550.0,"total_display":"33,550.00","total_whole":"33,550","shares_owned_after":90910.0,"shares_owned_after_display":"90,910","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-12","filed_date":"2026-06-12","scope":"insider"},{"id":4245574,"accession":"0001415889-25-014186","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-014186","line_url":"/filing/0001415889-25-014186#line-2","is_derivative":false,"issuer_cik":"0001398595","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001398595","owner_cik":"0001398595","owner_name":"Fitzpatrick Alexander A","owner_display_name":"Fitzpatrick Alexander A","owner_url":"/insider/0001398595","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":102969.0,"shares_display":"102,969","price_per_share":14.0966,"price_display":"14.10","price_state":"stated","total_value":1451512.8054,"total_display":"1,451,512.81","total_whole":"1,451,513","shares_owned_after":89613.0,"shares_owned_after_display":"89,613","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-20","filed_date":"2025-05-22","scope":"insider"},{"id":7871723,"accession":"0001209191-23-051073","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-051073","line_url":"/filing/0001209191-23-051073#line-2","is_derivative":false,"issuer_cik":"0001398595","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001398595","owner_cik":"0001398595","owner_name":"Fitzpatrick Alexander A","owner_display_name":"Fitzpatrick Alexander A","owner_url":"/insider/0001398595","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":46258.0,"shares_display":"46,258","price_per_share":3.783,"price_display":"3.78","price_state":"stated","total_value":174994.014,"total_display":"174,994.01","total_whole":"174,994","shares_owned_after":89227.0,"shares_owned_after_display":"89,227","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-29","filed_date":"2023-10-02","scope":"insider"},{"id":7871720,"accession":"0001209191-23-051073","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-051073","line_url":"/filing/0001209191-23-051073#line-1","is_derivative":false,"issuer_cik":"0001398595","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001398595","owner_cik":"0001398595","owner_name":"Fitzpatrick Alexander A","owner_display_name":"Fitzpatrick Alexander A","owner_url":"/insider/0001398595","role":"Officer (Chief Legal Officer)","role_mark":"O","role_mark_label":"Officer (Chief Legal Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Legal Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":3.624,"price_display":"3.62","price_state":"stated","total_value":144960.0,"total_display":"144,960.00","total_whole":"144,960","shares_owned_after":42969.0,"shares_owned_after_display":"42,969","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-28","filed_date":"2023-10-02","scope":"insider"},{"id":4701070,"accession":"0001618835-21-000273","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001618835-21-000273","line_url":"/filing/0001618835-21-000273#line-1","is_derivative":false,"issuer_cik":"0001398595","issuer_name":"Evofem Biosciences, Inc.","issuer_ticker":"EVFM","issuer_name_source":null,"issuer_url":"/issuer/0001398595","owner_cik":"0001398595","owner_name":"Fitzpatrick Alexander A","owner_display_name":"Fitzpatrick Alexander A","owner_url":"/insider/0001398595","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":0.389,"price_display":"0.39","price_state":"stated","total_value":9725.0,"total_display":"9,725.00","total_whole":"9,725","shares_owned_after":336422.0,"shares_owned_after_display":"336,422","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-20","filed_date":"2021-12-20","scope":"insider"},{"id":4432130,"accession":"0001618835-21-000146","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001618835-21-000146","line_url":"/filing/0001618835-21-000146#line-1","is_derivative":false,"issuer_cik":"0001398595","issuer_name":"Evofem Biosciences, Inc.","issuer_ticker":"EVFM","issuer_name_source":null,"issuer_url":"/issuer/0001398595","owner_cik":"0001398595","owner_name":"Fitzpatrick Alexander A","owner_display_name":"Fitzpatrick Alexander A","owner_url":"/insider/0001398595","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.025,"price_display":"1.02","price_state":"stated","total_value":10250.0,"total_display":"10,250.00","total_whole":"10,250","shares_owned_after":311422.0,"shares_owned_after_display":"311,422","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-10","filed_date":"2021-06-10","scope":"insider"},{"id":3001543,"accession":"0001618835-20-000246","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001618835-20-000246","line_url":"/filing/0001618835-20-000246#line-1","is_derivative":false,"issuer_cik":"0001398595","issuer_name":"Evofem Biosciences, Inc.","issuer_ticker":"EVFM","issuer_name_source":null,"issuer_url":"/issuer/0001398595","owner_cik":"0001398595","owner_name":"Fitzpatrick Alexander A","owner_display_name":"Fitzpatrick Alexander A","owner_url":"/insider/0001398595","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9090.0,"shares_display":"9,090","price_per_share":2.2,"price_display":"2.20","price_state":"stated","total_value":19998.0,"total_display":"19,998.00","total_whole":"19,998","shares_owned_after":143542.0,"shares_owned_after_display":"143,542","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-17","filed_date":"2020-11-18","scope":"insider"},{"id":6891761,"accession":"0001618835-18-000090","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001618835-18-000090","line_url":"/filing/0001618835-18-000090#line-2","is_derivative":false,"issuer_cik":"0001398595","issuer_name":"Evofem Biosciences, Inc.","issuer_ticker":"EVFM","issuer_name_source":null,"issuer_url":"/issuer/0001398595","owner_cik":"0001398595","owner_name":"Fitzpatrick Alexander A","owner_display_name":"Fitzpatrick Alexander A","owner_url":"/insider/0001398595","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":2.27,"price_display":"2.27","price_state":"stated","total_value":1135.0,"total_display":"1,135.00","total_whole":"1,135","shares_owned_after":75000.0,"shares_owned_after_display":"75,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-21","filed_date":"2018-08-21","scope":"insider"},{"id":6891757,"accession":"0001618835-18-000090","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001618835-18-000090","line_url":"/filing/0001618835-18-000090#line-1","is_derivative":false,"issuer_cik":"0001398595","issuer_name":"Evofem Biosciences, Inc.","issuer_ticker":"EVFM","issuer_name_source":null,"issuer_url":"/issuer/0001398595","owner_cik":"0001398595","owner_name":"Fitzpatrick Alexander A","owner_display_name":"Fitzpatrick Alexander A","owner_url":"/insider/0001398595","role":"Officer (General Counsel and Secretary)","role_mark":"O","role_mark_label":"Officer (General Counsel and Secretary)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"General Counsel and Secretary","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4500.0,"shares_display":"4,500","price_per_share":2.2,"price_display":"2.20","price_state":"stated","total_value":9900.0,"total_display":"9,900.00","total_whole":"9,900","shares_owned_after":74500.0,"shares_owned_after_display":"74,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-20","filed_date":"2018-08-21","scope":"insider"},{"id":9116160,"accession":"0001428789-11-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001428789-11-000006","line_url":"/filing/0001428789-11-000006#line-2","is_derivative":false,"issuer_cik":"0001049210","issuer_name":"VERENIUM CORP","issuer_ticker":"VRNM","issuer_name_source":null,"issuer_url":"/issuer/0001049210","owner_cik":"0001398595","owner_name":"Fitzpatrick Alexander A","owner_display_name":"Fitzpatrick Alexander A","owner_url":"/insider/0001398595","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7203.0,"shares_display":"7,203","price_per_share":1.9,"price_display":"1.90","price_state":"stated","total_value":13685.7,"total_display":"13,685.70","total_whole":"13,686","shares_owned_after":7496.0,"shares_owned_after_display":"7,496","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-19","filed_date":"2011-08-22","scope":"insider"},{"id":9116159,"accession":"0001428789-11-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001428789-11-000006","line_url":"/filing/0001428789-11-000006#line-1","is_derivative":false,"issuer_cik":"0001049210","issuer_name":"VERENIUM CORP","issuer_ticker":"VRNM","issuer_name_source":null,"issuer_url":"/issuer/0001049210","owner_cik":"0001398595","owner_name":"Fitzpatrick Alexander A","owner_display_name":"Fitzpatrick Alexander A","owner_url":"/insider/0001398595","role":"Officer (SVP & General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & General Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":293.0,"shares_display":"293","price_per_share":1.85,"price_display":"1.85","price_state":"stated","total_value":542.05,"total_display":"542.05","total_whole":"542","shares_owned_after":293.0,"shares_owned_after_display":"293","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-18","filed_date":"2011-08-22","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":9,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001671858","name":"ARS Pharmaceuticals, Inc.","url":"/issuer/0001671858","role":"Officer (Chief Legal Officer)","n_filings":3,"first_seen":"2023-10-02","last_seen":"2026-06-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001618835","name":"Evofem Biosciences, Inc.","url":"/issuer/0001618835","role":"Officer (General Counsel and Secretary)","n_filings":4,"first_seen":"2018-08-21","last_seen":"2021-12-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001049210","name":"VERENIUM CORP","url":"/issuer/0001049210","role":"Officer (SVP & General Counsel)","n_filings":1,"first_seen":"2011-08-22","last_seen":"2011-08-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001398595","retrieved_at":"2026-08-22T21:24:45+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}